Trending FOX BUSINESS News: Positive Results From Roche Phase III Trials Into Etrolizumab

Unknown October 31, 2017 0

Positive Results From Roche Phase III Trials Into Etrolizumab

Roche Holding AG (RO.EB) said Tuesday that new data from two ongoing phase-III trials evaluating etrolizumab in patients with inflammatory bowel disease, or IBD, indicated that patients showed an improvement.

via FOX BUSINESS NEWS
http://ift.tt/2z0QAv8

No comments

Subscribe to: Post Comments ( Atom )